NCT06965556

Brief Summary

Introduction Breast cancer remains a leading global health concern, with significant psychological challenges during the perioperative period. Traditional patient education focuses on disease management but often neglects emotional and cognitive needs. Perioperative inpatients are relatively stable and have the time and mental space for deeper education and psychological support. This study evaluates the clinical significance of a medical humanities-based education strategy for breast cancer patients during hospitalization, aiming to enhance psychological resilience, treatment adherence, and quality of life. Methods and Analysis This prospective, non-randomized, open-label study will include female patients with early-stage breast cancer scheduled for surgery at Fudan University Shanghai Cancer Center. Participants will be allocated to two cohorts: practical education group and mental enhanced group. The primary endpoint is psychological assessment at hospital discharge, including anxiety (GAD-7), depression (PHQ-9), and sleep quality (ISI). Secondary endpoints include the proportion of patients opting for breast-conserving procedures, incidence of postoperative complications, long-term treatment adherence (MMAS-8), patients' disease-coping resilience (CD-RISC-10), and quality of life assessment (EORTC QLQ instruments) at 12-month follow-up. Data collection and statistical analysis will be conducted using validated instruments and software, with significance set at p ≤0.05. Ethics and Dissemination Approved by the FUSCC ethics committee, all participants provide informed consent. Results will be disseminated through international conferences and peer-reviewed journals. The study adheres to ethical guidelines, ensuring data confidentiality via encrypted platforms. Authors declare no conflicts of interest, supported by Shanghai Municipal Science and Technology Innovation Action Plan (24DZ2303500). Findings aim to optimize perioperative education strategies, addressing psychological and informational needs of breast cancer patients.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,138

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jun 2025Oct 2026

First Submitted

Initial submission to the registry

April 16, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

1.4 years

First QC Date

April 16, 2025

Last Update Submit

May 11, 2025

Conditions

Keywords

breast carcinomapatient educationeducational comicpsychological interventionhospitalization

Outcome Measures

Primary Outcomes (3)

  • anxiety status at hospital discharge

    anxiety status at hospital discharge evaluated using the GAD-7 questionnaire Generalized Anxiety Disorder scale, GAD-7 (0-21 points): Cut-off values of 5, 10, and 15 delineated mild, moderate, and severe anxiety

    Five days after surgery

  • depression severity at hospital discharge

    depression severity at hospital discharge assessed with the PHQ-9 instrument Patient Health Questionnaire, PHQ-9 (0-27 points): Thresholds at 5, 10, 15, and 20 classified mild, moderate, moderately severe, and severe depression.

    Five days after surgery

  • sleep quality at hospital discharge

    sleep quality at hospital discharge measured via the ISI scale Insomnia Severity Index, ISI (0-28 points): Scores ≥8, ≥15, and ≥22 indicated subthreshold, moderate, and severe insomnia.

    Five days after surgery

Secondary Outcomes (9)

  • The proportion of patients opting for breast-conserving cosmetic procedures

    Five days after surgery

  • Incidence of postoperative complications requiring surgical intervention

    12 months follow-up

  • Long-term treatment adherence

    12 months follow-up

  • Patients' disease-coping resilience

    12 months follow-up

  • Quality of life assessment at discharge

    Five days after surgery

  • +4 more secondary outcomes

Study Arms (2)

Medical Humanities-based Patient Education Strategy

ACTIVE COMPARATOR

Mental Enhanced Education Strategy Patients allocated to the enhanced mental health education intervention cohort will receive supplemental medical humanities modules alongside the standard Practical Education Strategy during hospitalization. This content is derived from a comic publication compiled by the breast surgery team of Fudan University Shanghai Cancer Center, which narrates the 4600-year human battle against breast cancer in a grand story. The content combines humorous cartoons with novel-like text, covering the evolution of human understanding of breast cancer, and the emergence and development of various therapies, drugs, and technologies. For patients unable to read, audio books and dynamic cartoon videos are available on mobile devices. The general content framework is as follows: * Understanding of breast cancer in ancient Egypt and Persia; * Hippocratic-Galenic Theories: early management of breast disorders in Greco-Roman antiquity; * Traditional Chinese medical interpret

Other: Medical Humanities-based Patient Education Strategy

Routine Patient Education Strategy

NO INTERVENTION

Practical Education Strategy Admission Day * Comprehensive admission nursing assessment and introduction to care protocols: Admission assessment form, nutritional assessment, fall risk assessment, deep vein thrombosis risk assessment, pain assessment, etc. * Orientation to ward environment and policies: introduction to the medical team, online doctor-patient communication platform, ward facilities, daily routines, dietary guidelines, and other essential services, etc. * Review of medical history and guidance on preoperative examinations and precautions: Hematological tests, electrocardiogram, ultrasound, mammography, CT, MRI, core needle biopsy, fine needle aspiration, etc. Days Before Surgery * Personal preparation instructions: Bathing, hair washing, fasting, and fluid restriction guidelines, etc. * Interpretation of preoperative examination results. * Overview of common surgical approaches for breast cancer, introduction of surgery options based on the condition, especially emphasis on

Interventions

Medical Humanities-based Patient Education with Comic-based Medical Education Materials for Breast Cancer Patients during Perioperative Hospitalization Stage

Medical Humanities-based Patient Education Strategy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • More than 18 years old
  • Female
  • Patient with early-stage breast cancer with preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ
  • No clinical or imaging evidence of distant metastasis
  • Patients to receive breast surgery during hospitalizaiton (including mastectomy, breast conserving therapy, reconstrucion, etc.)
  • Be able and willing to sign the Informed Consent Form (ICF)

You may not qualify if:

  • Patients with locally advanced breast cancer to receive neoadjuvant therapy
  • Patients currently participating in other clinical trials, which may have impact on the participation in this trial
  • Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, 200032, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Jiajian Chen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 16, 2025

First Posted

May 11, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations